GE Healthcare Technologies Inc (GEHC) does not present a compelling buy opportunity for a beginner investor with a long-term horizon at this time. The stock is currently under pressure due to macroeconomic challenges, rising input costs, and a weaker-than-expected earnings outlook. While insiders are buying and the stock has potential for long-term growth, the lack of strong positive catalysts and bearish technical indicators suggest a wait-and-see approach is more prudent.
The technical indicators are bearish. The MACD histogram is negative and expanding downward, RSI is neutral but leaning toward oversold territory, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 60.983) with resistance levels at R1: 65.926 and R2: 67.453.

Insiders are buying, with a significant increase of 1425.73% in insider purchases over the last month. Congress trading data shows balanced activity, with one purchase transaction. The stock has an 80% chance of gaining 10.99% in the next month based on historical candlestick patterns.
Hedge funds are selling, with a 129.92% increase in selling activity over the last quarter. Analysts have significantly lowered price targets across the board, citing weaker margins, inflationary pressures, and macroeconomic challenges. The company also missed Q1 earnings and reduced its 2026 EPS guidance.
No detailed financial data is available for analysis, but analysts have highlighted weaker-than-expected Q1 earnings and reduced 2026 EPS guidance due to rising input costs and macroeconomic headwinds.
Analysts have downgraded the stock and lowered price targets significantly. The consensus is mixed, with some maintaining Outperform ratings, but many have shifted to Neutral or downgraded the stock. The reduced earnings outlook and macro pressures are key concerns, despite some long-term growth potential.